190 related articles for article (PubMed ID: 27378276)
1. Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris.
Rodríguez-López A; Alméciga-Díaz CJ; Sánchez J; Moreno J; Beltran L; Díaz D; Pardo A; Ramírez AM; Espejo-Mojica AJ; Pimentel L; Barrera LA
Sci Rep; 2016 Jul; 6():29329. PubMed ID: 27378276
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
[TBL] [Abstract][Full Text] [Related]
3. Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS).
Alméciga-Díaz CJ; Tolosa-Díaz AD; Pimentel LN; Bonilla YA; Rodríguez-López A; Espejo-Mojica AJ; Patiño JD; Sánchez OF; Gonzalez-Santos J
Gene; 2017 Nov; 634():53-61. PubMed ID: 28882567
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.
Alméciga-Díaz CJ; Montaño AM; Tomatsu S; Barrera LA
FEBS J; 2010 Sep; 277(17):3608-19. PubMed ID: 20716181
[TBL] [Abstract][Full Text] [Related]
5. Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.
Alméciga-Diaz CJ; Hidalgo OA; Olarte-Avellaneda S; Rodríguez-López A; Guzman E; Garzón R; Pimentel-Vera LN; Puentes-Tellez MA; Rojas-Rodriguez AF; Gorshkov K; Li R; Zheng W
J Med Chem; 2019 Jul; 62(13):6175-6189. PubMed ID: 31188588
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris.
Pimentel N; Rodríguez-Lopez A; Díaz S; Losada JC; Díaz-Rincón DJ; Cardona C; Espejo-Mojica ÁJ; Ramírez AM; Ruiz F; Landázuri P; Poutou-Piñales RA; Cordoba-Ruiz HA; Alméciga-Díaz CJ; Barrera-Avellaneda LA
Biotechnol Appl Biochem; 2018 Sep; 65(5):655-664. PubMed ID: 29633336
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype-phenotype correlation for Morquio A.
Olarte-Avellaneda S; Rodríguez-López A; Alméciga-Díaz CJ; Barrera LA
Mol Biol Rep; 2014 Nov; 41(11):7073-88. PubMed ID: 25287660
[TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
9. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase.
Tomatsu S; Montaño AM; Gutierrez M; Grubb JH; Oikawa H; Dung VC; Ohashi A; Nishioka T; Yamada M; Yamada M; Tosaka Y; Trandafirescu GG; Orii T
Mol Genet Metab; 2007 May; 91(1):69-78. PubMed ID: 17336563
[TBL] [Abstract][Full Text] [Related]
10. Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase.
Alméciga-Díaz CJ; Rueda-Paramo MA; Espejo AJ; Echeverri OY; Montaño A; Tomatsu S; Barrera LA
Mol Biol Rep; 2009 Sep; 36(7):1863-70. PubMed ID: 18989752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HIV-1 derived lentiviral vectors as transductors of Mucopolysaccharidosis type IV a fibroblasts.
Puentes-Tellez MA; Sánchez OF; Rojas-Rodriguez F; Benincore-Flórez E; Barbosa H; Alméciga Díaz CJ
Gene; 2021 May; 780():145527. PubMed ID: 33636292
[TBL] [Abstract][Full Text] [Related]
12. Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21.
Hernández A; Velásquez O; Leonardi F; Soto C; Rodríguez A; Lizaraso L; Mosquera Á; Bohórquez J; Coronado A; Espejo Á; Sierra R; Sánchez OF; Alméciga-Díaz CJ; Barrera LA
J Microbiol Biotechnol; 2013 May; 23(5):689-98. PubMed ID: 23648860
[TBL] [Abstract][Full Text] [Related]
13. The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.
Rivera-Colón Y; Schutsky EK; Kita AZ; Garman SC
J Mol Biol; 2012 Nov; 423(5):736-51. PubMed ID: 22940367
[TBL] [Abstract][Full Text] [Related]
14. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
Tomatsu S; Vogler C; Montaño AM; Gutierrez M; Oikawa H; Dung VC; Orii T; Noguchi A; Sly WS
Mol Genet Metab; 2007 Jul; 91(3):251-8. PubMed ID: 17498992
[TBL] [Abstract][Full Text] [Related]
15. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
16. Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts.
Flanagan M; Pathak I; Gan Q; Winter L; Emnet R; Akel S; Montaño AM
Stem Cell Res Ther; 2021 May; 12(1):276. PubMed ID: 33957983
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy in a murine model of Morquio A syndrome.
Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
[TBL] [Abstract][Full Text] [Related]
18. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.
Sukegawa K; Nakamura H; Kato Z; Tomatsu S; Montaño AM; Fukao T; Toietta G; Tortora P; Orii T; Kondo N
Hum Mol Genet; 2000 May; 9(9):1283-90. PubMed ID: 10814710
[TBL] [Abstract][Full Text] [Related]
20. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).
Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T
Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
